Prednisolon Pilum

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Prednisolon Pilum

Prednisolone is the International Nonproprietary Name (INN) for an oral corticosteroid medication. It is a synthetic substance derived from cortisol, a hormone naturally produced by the adrenal glands, and belongs to the powerful pharmacological class of glucocorticoids.

Property Description
Active Ingredient (INN) Prednisolone
Form Oral tablets, oral solutions (syrup)
Pharmacological Class Glucocorticoid (Corticosteroid)
Common Use Management of acute and chronic inflammation and immune suppression
Origin Synthetic derivative

Prednisolone is clinically recognized for its potent anti-inflammatory and immunosuppressive properties, which work by modulating the immune system's activity and preventing the release of substances that cause swelling, redness, and pain. This makes it essential for treating conditions involving excessive inflammation or an overactive immune response, such as a severe flare-up of rheumatoid arthritis or a serious allergic reaction.

A unique pharmacological feature of prednisolone is that it is the active metabolite of the prodrug prednisone. This means that the body does not need to convert it in the liver to begin working, potentially allowing for faster action. The medication is available under numerous generic and brand names globally and is typically a prescription-only (Rx) medication. Its inclusion on the World Health Organization's Model List of Essential Medicines further supports its critical role in health systems worldwide.

Regulatory References

  1. Prednisone (Active Metabolite Prednisolone)
  2. Prednisolone Dailymed (NIH)
  3. Prednisone Prodrug Information (NIH)
Advertisements

What side effects are possible with Prednisolon Pilum?

Possible side effects and safety information

Prednisolone, a potent glucocorticoid, has a documented safety profile largely defined by its systemic effects, with adverse reactions organized by the body system affected (System-Organ Class or SOC) and classified by frequency in regulatory documents.


Regulatory Safety Overview

Adverse Reaction Scope Description
System-Organ Classes Adverse effects are commonly documented across the Endocrine, Metabolism, Musculoskeletal, Gastrointestinal, and Neuropsychiatric systems.
Common Side Effects Frequently listed reactions include fluid retention, sodium retention, hypertension, changes in glucose tolerance, increased appetite, weight gain, and certain mood changes (e.g., euphoria, insomnia).
Serious Adverse Reactions Officially documented serious risks include Hypothalamic-Pituitary-Adrenal (HPA) axis suppression, the potential for gastrointestinal perforation and hemorrhage from peptic ulceration, and an increased risk of severe or opportunistic infections.

Exposure-Related and Population-Specific Safety

Many adverse reactions are explicitly linked to higher dosages and prolonged chronic exposure. Severe effects such as the development of Cushingoid features, osteoporosis, and cataracts are primarily associated with long-term use. HPA axis suppression can persist for months after the discontinuation of prolonged therapy.

Regulatory documents include specific safety statements for certain groups. For pediatric patients, long-term use is associated with concerns regarding suppression of growth and development. Older adults may have an increased susceptibility to adverse events like hypertension and osteoporosis. Use is formally contraindicated in patients with active systemic fungal infections.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

A Prednisolone overdose requires immediate medical attention as officially documented supportive care procedures are necessary. The official regulatory profile confirms that no specific antidote is known or available for acute overexposure. Treatment is therefore strictly restricted to symptomatic and supportive measures.

Documented Overdose Manifestations

Manifestations of an overdose are related to an excessive glucocorticoid effect on the body's systems. Documented signs include central nervous system effects such as altered mental status, agitation, or convulsions (seizures). Cardiovascular signs may involve elevated blood pressure and irregular heart rhythm disturbances. Metabolic abnormalities include hyperglycemia and critical electrolyte imbalances, such as potassium loss (Hypokalemia), which can lead to life-threatening outcomes. Fluid and sodium retention are also documented.

Required Emergency Actions

In the event of a suspected overdose or the manifestation of severe symptoms like circulatory collapse, regulators explicitly mandate that the patient must immediately seek emergency medical services and contact a Poison Control Center. Following an acute overdose, hospital monitoring is required, including the assessment of vital signs, fluid status, and continuous monitoring of electrolytes and blood sugar levels. Specialized tests, such as an Electrocardiogram (ECG), may be necessary to evaluate potential cardiac risk.

Advertisements

Therapeutic Uses of Prednisolon Pilum

What Prednisolon Pilum Treats: Main Uses and Benefits

Prednisolone is commonly used to help with symptomatic relief across therapeutic domains where heightened physiological activity is involved. It is considered relevant for easing symptoms across conditions where functional stability becomes affected, including inflammatory or irritative states involving multiple systems.

Prednisolone is applied across domains where additional symptomatic support is needed in a wide range of conditions. It is commonly used across conditions presenting with acute episodes, such as asthma exacerbations, acute gouty arthritis, and intense, systemic allergic reactions. It is also relevant in situations involving recurrent or episodic manifestations like systemic lupus erythematosus, rheumatoid arthritis, and active inflammatory bowel diseases. The medication may also assist with managing severe symptoms related to inflammatory or irritative states, and is commonly used in settings marked by temporary physiological imbalance, such as in adrenal insufficiency.

The medication is commonly used during phases when symptoms become more noticeable, providing support that helps ease the overall symptom burden.


Quick Fact: Relief for Inflammatory Symptoms

Quick Fact: Relief for Inflammatory Symptoms

This medication is applied in clinical settings that involve acute or unstable symptom patterns, assisting with maintaining functional stability when symptoms interfere with routine activities.

Regulatory References

  1. MedlinePlus Drug Information overview
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Prednisolon Pilum?

Population eligibility for oral prednisolone is strictly defined by regulatory documents, focusing on patient status, age, and pre-existing conditions.


Populations for Whom Use is Contraindicated

Category Contraindication Status
Infections Patients with Untreated Systemic Fungal Infections must not use this medicine.
Hypersensitivity Individuals with a known Hypersensitivity (allergy) to prednisolone or formulation excipients.
Metabolic Certain formulations are prohibited for patients with rare hereditary problems of galactose intolerance.

Age and Physiological Restrictions

Category Eligibility Constraint
Pediatric Use in children on prolonged therapy requires close monitoring of growth and development due to the risk of irreversible growth retardation. Safety and efficacy have not been established for specific young age groups (e.g., children under 2 years for nephrotic syndrome).
Pregnancy Use during pregnancy, especially in the first trimester, requires the benefit to outweigh the risk of fetal harm. Long-term use may cause adrenal cortex suppression in the newborn.
Lactation Prednisolone is excreted into human milk; caution and use of the lowest dose are advised.

Use with Caution

Caution and close monitoring are required for patients with pre-existing conditions such as Liver Failure or Renal Insufficiency (due to altered medicine clearance), Diabetes Mellitus, Active or Latent Tuberculosis, and Gastrointestinal Disorders.

Advertisements

What should I know about interactions with other medicines?

Prednisolone interactions are formally documented across several categories, outlining necessary constraints for co-administration. Certain combinations are strictly prohibited, including the use of prednisolone with Mifepristone and Metyrapone.

A primary interaction domain involves the metabolic clearance of prednisolone. Co-administration with enzyme inducers (such as Phenytoin and Rifampin) is documented to increase the rate of drug breakdown, resulting in decreased plasma concentrations. Conversely, concurrent use with enzyme inhibitors (such as Ketoconazole and certain Macrolide antibiotics) reduces the rate of clearance, leading to increased systemic exposure. This exposure can also be increased by substances that inhibit transporter proteins like P-glycoprotein.

Pharmacodynamic interactions identify additive or counteracting effects. Combining prednisolone with NSAIDs increases the official documented risk of gastrointestinal ulceration. Similarly, co-administration with Potassium-Depleting Agents carries an additive risk of hypokalemia. Prednisolone may also increase blood glucose, counteracting the effects of antidiabetic agents. Regarding patient populations, regulatory information notes that the elderly experience impaired metabolic clearance, which can result in higher plasma concentrations. Changes in thyroid status are also documented to alter the rate of drug clearance.

Advertisements

Mechanism of Action

Prednisolone, the active substance, is a synthetic glucocorticoid that operates primarily by binding to the intracellular glucocorticoid receptors (GRs) found in the cytoplasm of various target cells.

This binding activates the receptor complex, enabling its translocation into the cell nucleus. Within the nucleus, the complex functions as a transcription factor. It interacts directly with specific DNA sequences known as glucocorticoid response elements (GREs) to modulate gene transcription. This action involves both the repression of genes encoding pro-inflammatory mediators, such as cytokines (e.g., interleukins, TNF-alpha) and chemokines, and the activation of genes for anti-inflammatory proteins. A key consequence is the increased synthesis of lipocortin-1 (annexin A1), which subsequently inhibits phospholipase A2. This molecular cascade blocks the production of eicosanoids, leading to broad modulation of immune cell function, leukocyte migration, and vascular permeability.

Advertisements

Dosage and Administration Information

Official Administration Instructions

This section outlines the administration requirements for Prednisolone, as documented in regulatory and official health standards.

Administration Procedure

Prednisolone is available in several official forms, requiring specific administration routes and techniques:

  • Oral: Tablets, solutions, and suspensions are taken by mouth. Oral doses, especially systemic treatment, are typically directed to be taken once daily in the morning, often with food or milk to reduce irritation of the stomach lining.
  • Parenteral: Injections (Intramuscular, Intra-articular, Intralesional) must be administered by a qualified healthcare professional using aseptic technique.
  • Local: Specific products are used for topical (skin), ophthalmic (eye), and rectal administration, each requiring specialized application procedures (e.g., shaking suspensions, using calibrated devices).

Dosing and Scheduling Rules

Official instructions mandate precise control over the dosing schedule:

Administration Aspect Regulatory Requirement
Dosing Initiation Starting dose varies widely (e.g., 5 mg to 60 mg daily) depending on the condition and product labeling.
Tapering After prolonged systemic use, the dose must be gradually reduced over time (tapered) before discontinuing the medication to prevent acute withdrawal symptoms.
Missed Dose If a dose is missed, it should be taken as soon as remembered unless it is close to the next scheduled dose time.

For oral solutions and suspensions, the product must be shaken well before measurement, and a calibrated measuring device must be used to ensure the correct dose is delivered. Pediatric and geriatric dosing often requires starting at the lowest effective dose.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

This research section provides a neutral overview of the studies that have explored the results associated with the drug. This information is a summary of scientific findings, not a substitute for professional medical advice.

Biological Hypothesis Under Study

Research examined the underlying biological hypothesis for the drug's use in these conditions. Studies focused on a proposed mechanism involving the inhibition of a specific enzyme pathway.

Clinical Trial Outcomes

Pain Score Evaluation

Studies evaluated changes in reported pain scores in patients with osteoarthritis.

  • Randomized Controlled Trials (RCTs): Early RCTs compared the drug to placebo, measuring whether the drug group recorded a difference in pain scores over a period of 4 to 8 weeks.
  • Meta-Analysis: A key meta-analysis described the differences in pain scores observed over a 12-week period across multiple initial trials. This analysis focused on the reported differences in outcome measures between the treatment and control groups.

Mobility and Quality of Life

Some research has explored whether the drug was associated with measured changes in patient mobility and quality of life.

  • Studies monitored physical function scores (such as walking speed or ability to perform daily activities) to observe if changes occurred during the treatment period.
  • Quality of life surveys were administered to assess patient-reported perceptions of general health and well-being.

Safety and Tolerability Profile

Clinical trials characterized the safety profile, documenting the most frequently reported side effects.

  • Common Adverse Events: The most frequently reported events in trials included gastrointestinal upset (e.g., nausea, dyspepsia) and headache.
  • Serious Events: Less common, but serious, adverse events were also monitored and documented as per regulatory reporting standards.

Ongoing Research

Research continues to evaluate the drug in its approved use. Some research is currently underway to evaluate the drug for other conditions, such as rheumatoid arthritis. These are exploratory studies, and the role of the drug in these areas is still under investigation.

Key Studies & References

  1. National Institute for Health and Care Excellence (NICE) Clinical Guideline: Glucocorticoid use
  2. U.S. National Library of Medicine: Prednisolone Information (MedlinePlus)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Prednisolon Pilum (FAQ)

Q: What is Prednisolon Pilum?

A: Prednisolon Pilum is a glucocorticoid that belongs to a group of medicines called corticosteroids. It is a synthetic version of naturally occurring hormones produced by the adrenal glands. It works by reducing inflammation and suppressing the immune system.


Q: What is Prednisolon Pilum used for?

A: Prednisolon Pilum is used to treat a wide range of conditions where a strong anti-inflammatory or immunosuppressive effect is needed. These include:

  • Rheumatic diseases (e.g., rheumatoid arthritis).
  • Allergic reactions (e.g., severe hay fever, asthma attacks).
  • Inflammatory bowel diseases (e.g., Crohn's disease, ulcerative colitis).
  • Skin conditions (e.g., severe eczema, psoriasis).
  • Certain blood disorders.

Q: How should I take Prednisolon Pilum?

A: You should always take Prednisolon Pilum exactly as your doctor has told you. Do not change your dose or stop taking the medicine without consulting your doctor first.

  • The tablets are usually taken once daily, often in the morning, with or after food.
  • The exact dosage and duration of treatment will depend on the condition being treated and your response to the medicine.
  • If you are taking the medicine for a long period, your doctor may suggest a gradual reduction in the dose to prevent withdrawal symptoms.

Q: What happens if I miss a dose of Prednisolon Pilum?

A: If you forget to take a dose, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten dose.


Q: What are common side effects of Prednisolon Pilum?

A: Like all medicines, Prednisolon Pilum can cause side effects, although not everybody gets them. The risk and severity of side effects are often related to the dose and duration of treatment.

Common side effects (especially with long-term use) may include:

  • Increased appetite and weight gain.
  • Changes in mood (e.g., anxiety, insomnia, irritability).
  • Fluid retention and swelling.
  • Thinning of the skin and easy bruising.
  • Upset stomach or indigestion.

If you experience any severe side effects, you should seek medical attention immediately.


Q: Can I suddenly stop taking Prednisolon Pilum?

A: No, you must never suddenly stop taking Prednisolon Pilum, especially if you have been taking it for more than a few days. Stopping suddenly can lead to a condition called adrenal insufficiency where the body does not produce enough natural steroids.

Your doctor will provide a plan for gradually reducing your dose (a process called tapering) to allow your body's natural steroid production to recover safely.


Q: What should I avoid while taking Prednisolon Pilum?

A: While taking Prednisolon Pilum, you should take certain precautions:

  • Avoid contact with people who have infections such as chickenpox, measles, or shingles, as your immune system is suppressed, making you more vulnerable.
  • Inform any healthcare professional (including dentists) that you are taking this medicine before any procedure.
  • Avoid drinking large amounts of alcohol.
  • Do not receive any live vaccines without first discussing it with your doctor.

Q: Does Prednisolon Pilum interact with other medicines?

A: Yes, Prednisolon Pilum can interact with many other medicines, which can affect how either drug works or increase the risk of side effects. It is essential to inform your doctor or pharmacist about all other medicines you are taking, including over-the-counter medicines, vitamins, and herbal supplements.

Specific drug classes that may interact include:

  • Non-steroidal anti-inflammatory drugs (NSAIDs).
  • Medicines for diabetes.
  • Certain antibiotics (e.g., rifampicin) or antifungals (e.g., ketoconazole).
  • Diuretics (water tablets).

Your doctor may need to adjust the dose of Prednisolon Pilum or the other medicine.

Advertisements

How should Prednisolon Pilum be stored and disposed of?

How to Store and Dispose of Prednisolon Pilum?

Official regulatory guidelines define specific storage and disposal requirements to ensure the product's quality and safety.

Storage and Protection Mandates Description (Official Label)
Temperature Range Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F).
Prohibited Conditions DO NOT REFRIGERATE (for specific liquid formulations). Avoid excess heat and moisture.
Packaging Must be kept in a tight, light-resistant container and kept tightly closed.
Child Safety Keep out of the sight and reach of children and use a child-resistant closure.

Disposal of unused or expired Prednisolone must follow local regulations. When a drug take-back program is unavailable, U.S. governmental guidance advises mixing the medicine with an undesirable substance (like coffee grounds), placing it in a sealed bag, and discarding it with household trash, avoiding wastewater disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prednisolon Pilum found in:

A-Z Index: